Published: Sat, May 05, 2018
Sport | By Gary Shelton

Allscripts Healthcare Solutions, Inc. (MDRX) — Trending Stock Analysis

Allscripts Healthcare Solutions, Inc. (MDRX) — Trending Stock Analysis

Its down 0.18, from 1.16 in 2017Q3. Blackrock, a New York-based fund reported 19.31 million shs.

While looking at the Stock's Performance, Allscripts Healthcare Solutions, Inc. now shows a Weekly Performance of -4.17%, where Monthly Performance is -1.76%, Quarterly performance is -21.46%, 6 Months performance is -13.77% and yearly performance percentage is -4.41%. 36 funds took positions and 66 increased positions. Black Paul also sold $215,292 worth of Allscripts Healthcare Solutions, Inc. On Tuesday, January 16 SunTrust downgraded Allscripts Healthcare Solutions, Inc. Allscripts Healthcare Solutions Inc's shareholder Glenhill Advisors Llc owns 2.46 million shares as of 2017 Q4. Dalton Greiner Hartman Maher & Co. now owns 2,990,902 shares of the software maker's stock worth $43,518,000 after acquiring an additional 465,037 shares during the period. The Pennsylvania-based fund S&T Bank Pa looks positive on Allscripts Healthcare Solutions Inc, having 703,223 shares.

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. The companyÂ's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The firm's revenue for the quarter was up 24.9% on a year-over-year basis. analysts expect that Allscripts will post 0.56 earnings per share for the current year. MDRX has also 511,521 shares volume. The stock underperformed the S&P 500 by 18.18%. Mufg Americas Corp reported 1,000 shs.

The Company ended its previous trading session at $35.39 with the gain of 0.23%. Victory Management stated it has 0.05% of its capital in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 176,750 shs. Systematic Financial L P invested 0.62% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). 75,235 are held by Meeder Asset Management. Rhumbline Advisers holds 0.01% or 372,806 shs. Zeke Capital Advsr Limited Liability accumulated 11,340 shs. (NASDAQ:MDRX). Ing Groep Nv holds 0.01% or 27,263 shs. Mason Street Ltd, Wisconsin-based fund reported 89,015 shs. Community Tru And Investment stated it has 597,418 shs. Gotham Asset invested in 0.01% or 57,019 shs. Geode Capital Mgmt Ltd has 1.91M shs.

Some buy side analysts are also providing their Analysis on Allscripts Healthcare Solutions, Inc., where 5 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it's a HOLD, and 0 analysts rated the stock as Sell.

Trump says lawyers have advised him against Mueller talks
His view of Mueller soured further after raids last month that targeted one of his personal lawyers, Michael Cohen, in a separate investigation.

Since December 14, 2017, it had 0 insider buys, and 5 selling transactions for $772,395 activity. Another trade for 5,000 shares valued at $68,629 was made by Farley Brian on Wednesday, March 14.

On 12/15/2017 Richard J Poulton, President, sold 15,000 with an average share price of $14.26 per share and the total transaction amounting to $213,900.00. Goldman Sachs Gru Incorporated has invested 0.03% in Allscripts Healthcare Solutions, Inc.

In total 10 analysts cover Allscripts (NASDAQ:MDRX).

MDRX is touching $11.64 during the last trading session, after increased 1.04%.Allscripts Healthcare Solutions, downtrending after having declined 6.63% since May 5, 2017. On Friday, February 16 the rating was maintained by Canaccord Genuity with "Buy". On Tuesday, April 24 J.P. Morgan initiated Allscripts Healthcare Solutions, Inc. On Tuesday, January 16 the firm earned "Hold" rating by SunTrust. "It's a role Allscripts is proud to play-to improve the way patients engage with their own health and their clinicians is to fuel the progress of healthcare itself". The company rating was maintained by Cowen & Co on Wednesday, April 18. Allscripts plans to integrate HealthGrid's solutions into the FollowMyHealth platform and add functionality that will enable providers to reach 100 percent of their patient populations without requiring that patients first sign up for a patient portal. Cantor Fitzgerald maintained it with "Buy" rating and $1800 target in Tuesday, March 27 report. $17.05's average target is 46.48% above currents $11.64 stock price. "It's a role Allscripts is proud to play-to improve the way patients engage with their own health and their clinicians is to fuel the progress of healthcare itself".

Like this: